RISK FACTORS AND PATHOGENETIC SUBTYPES OF ISCHEMIC STROKE

Authors

  • Rakhimbayeva Gulnora Sattarovna
  • Musayeva Yulduz Alpisovna
  • Majidov Laziz Naimovich
  • Karimova Nilufar Mominjovona
  • Karimberdiev Aziz Davronovich
  • Xatamov Sardor Ismatulaevich
  • Mamedov Eldar Elxanovich
  • Rakhimov Xudoyor Bakhtiyarovich

Keywords:

IS-ischemic stroke; AF-atrial fibrillation; LS-lacunar stroke; BP-blood pressure; AH- arterial hypertension; MI-myocardial infarction; LS-lacunar stroke

Abstract

Ischemic stroke (IS) is the second or third most common cause of death in the population and the leading cause of disability among the elderly. According to international epidemiological studies, stroke occupies a leading place in the structure of both mortality and disability of the population and is a serious medical and socio-economic problem for society. Statistical studies conducted in a number of the CIS countries, including Uzbekistan, indicate a rejuvenation of strokes and an increase in the proportion of young women and an increase in the incidence of new strokes among rural residents. [31]

References

Дамулин ИВ,, Парфенов ВА, Скоромец АА., Ях-но НН. Нарушения кровообращения в головном и спинном мозге. В кн.: «Болезни нервной системы. Руководство для врачей»/Под ред. Н.Н. Ях-но. - М. Медицина, 2005. - Т. 1. - С. 231-302.

Инсульт: диагностика, лечение и профилак-тика./Под ред. ЗА. Суслиной, МА. Пирадова. -М.: МЕДпресс-информ, 2008. - 288 с.

Скворцова ВИ, ГубскийЛВ, СтаховскаяЛВ. и др. Ишемический инсульт. В книге «Неврология, национальное руководство»./ Под редакцией Е.И. Гусева, А.И. Коновалова, В.И. Скворцовой. М.: «ГЭОТАР- МЕДИА», 2009. - С. 592-615.

Brown RD, WhisnantJP, Sicks JD, et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.// Stroke. 1996; 27: 373-380.

Appelros P, StegmayrB, Terent A Sex Differences in Stroke Epidemiology//Stroke. 2009; 40:1082-1090.

Liao D, Myers R, Hunt S, et al. Familial history of stroke and stroke risk: the Family Heart Study.// Stroke. 1997; 28: 1908-1912.

Kalimo H, Viitanen M, Amberla K, et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia.//Neuropathol Appl Neurobiol. 1999; 25: 257-265.

Shinton R, Beevers G.. Meta-analysis of relation between cigarette smoking and stroke.//BMJ. 1989; 298: 789-794.

Bhat VM, ColeJ W, SorkinJD, et al. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women// Stroke. 2008; 39: 2439-2443.

AmbroseJA., Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update./// Am Coll Cardiol. 2004; 43: 1731-1737.

Reynolds K, Lewis B, NolenJD, et al. Alcohol consumption and risk of stroke: a meta- analysis.// JAMA. 2003; 289:579-588.

Suk SH, Sacco RL, Boden- Abala B, et al. For the Northern Manhattan Stroke Study. Abdominal obesity and risk of ischemic stroke: the Northern

Manhattan Stroke Study.//Stroke. 2003; 34: 1586-1592.

Lloyd-Jones D, Adams R., Carnethon M, et al: American Heart Association: Heart disease and stroke. Statistics 2009. Update.//Circulation 2009; 119: e1-el6l.

Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000strokes in

000 people in 45 prospective cohorts// Lancet. - 1995. - Vol. 346. - P. 1647-1653.

European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack//Cerebrovasc Dis. -2008; 25: 457-507.

Loh E, Sutton M.S., Wun C.C., et al. Ventricular dysfunction and the risk of stroke after myocardial infarction.//N Engl J Med. 1997; 336: 251-257.

De Castro S, Cartoni D , FiorelliM, et al.

Morphological and functional characteristics of patent foramen ovale and their embolic implications.//Stroke. 2000; 31:2407-2413.

Saposnik G, Ray J.G, Sheridan P., et al. Homocysteine- Lowering Therapy and Stroke Risk, Severity, and Disability//Stroke. 2009; 40: 1365-1372.

Nadareishvili Z.G., Rothwell PM, Beletsky V., et al. Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis.//Arch Neurol. 2002; 59: 1162-1166.

Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately

000 cases and 58,000 controls.//Arch Neurol. 2004; 61: 1652-1661.

Anticardiolipin antibodies are an independent risk factor for first ischemic stroke: the Antiphospholipid Antibodies in Stroke Study (APASS) Group.//Neurology. 1993; 43: 2069-2073.

Levine SR, Brey RL, Tilley B.C., et al. Antiphospholipid antibodies and subsequent thrombo- occlusive events in patients with ischemic stroke//JAMA. 2004; 291:576-584.

Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors.//Blood. 1998; 91: 288-294.

Schurks M, Rist PM., Bigal ME,, et al. Migraine and cardiovascular disease: systematic review and meta- analysis//BMJ. 2009; 339: b3914.

Lavie P., Lavie L. Cardiovascular morbidity and mortality in obstructive sleep apnea//Curr Pharm Des. 2008; 14:3466-3473.

AM Dzhuraev, RD Khalimov Our experience in the surgical treatment of Perthes disease in children. Postgraduate Physician 2012. N1.3 Том 50.Р. 377-383.

Sacco RL, EllenbergJH,, MohrJ P, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank.//Ann Neurol 1989; 25: 382-390.

Adams HP. Jr, Bendixen BH, Kappelle LJ. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment.//Stroke. 1993; 24: 35-41.

Amarenco P., Bogousslavsky J, Caplan LR, et al. Classification of Stroke Subtypes//Cerebrovasc Dis 2009; 27: 493-501.

В.А. Парфенов, д.м.н., проф., С.В. Вербицкая Первый МГМУ им. И.М. Сеченова. Основные фактори риска инсультов 2012;

Yu. A. Musaeva TTA Asab kasalliklari va Tibbiy psixologiya kafedrasi t.f.n dotsenti. Optimization of approaches to the treatment of acute ischemic stroke of cardiogenic etiology 2022;

Максимова М.Ю., Гулевская Т.С.М.: Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2019;119(8):13-27

Мусаева Ю.А. Роль гомоцистеина при прогнозировании риска развития ишемического инсульта кардиальной патологии. Узбекистон врачлар ассоциацияси бюллетени, 2021 №3

Мусаева Ю.А.Оценка эффективности препарата Лавиен в остром периоде ишемического инсульта кардиогенной этиологии и его вторичные гемодинамические эффекты.Journal of neurology and neurosurgery research .2022№1.

Мусаева Ю.А.Сличение клинического и патоморфологического диагнозов ишемического инсульта в сочетании с инфарктом миокарда. Journal of neurology and neurosurgery research .2022№1.

Downloads

Published

2023-02-03